{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:00:07Z","timestamp":1776510007316,"version":"3.51.2"},"reference-count":100,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T00:00:00Z","timestamp":1667692800000},"content-version":"vor","delay-in-days":2927,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Systems Biology program","award":["ARO-W911NF-10-1-0376"],"award-info":[{"award-number":["ARO-W911NF-10-1-0376"]}]},{"name":"NIH-DOD TACTI","award":["1-UM-1-HL120877-1"],"award-info":[{"award-number":["1-UM-1-HL120877-1"]}]},{"DOI":"10.13039\/100009045","name":"Jagiellonian University Medical College","doi-asserted-by":"crossref","award":["K\/ZDS\/002936"],"award-info":[{"award-number":["K\/ZDS\/002936"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1111\/jth.12728","type":"journal-article","created":{"date-parts":[[2014,9,12]],"date-time":"2014-09-12T04:48:51Z","timestamp":1410497331000},"page":"1776-1787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid"],"prefix":"10.1016","volume":"12","author":[{"given":"A.","family":"Undas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Brummel\u2010Ziedins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.G.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.12728_bb0010","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1046\/j.1538-7836.2003.00433.x","article-title":"Discovery of the antiplatelet effect of aspirin: a personal reminiscence","volume":"1","author":"Weiss","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"Suppl. 1","key":"10.1111\/jth.12728_bb0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1538-7836.2009.03391.x","article-title":"Aspirin, 110\u00a0years later","volume":"7","author":"Patrono","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"3 Suppl.","key":"10.1111\/jth.12728_bb0020","doi-asserted-by":"crossref","first-page":"234S","DOI":"10.1378\/chest.126.3_suppl.234S","article-title":"Platelet\u2010active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Patrono","year":"2004","journal-title":"Chest"},{"key":"10.1111\/jth.12728_bb0025","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJM198411083111902","article-title":"Dose\u2010related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenase","volume":"311","author":"Pedersen","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12728_bb0030","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/jth.12637","article-title":"Reappraisal of the clinical pharmacology of low\u2010dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action","volume":"12","author":"Patrignani","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0035","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1182\/blood.V82.2.505.505","article-title":"Aspirin does not inhibit adenosine diphosphate\u2010induced platelet a\u2010granule release","volume":"82","author":"Rinder","year":"1993","journal-title":"Blood"},{"key":"10.1111\/jth.12728_bb0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.thromres.2003.08.026","article-title":"Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry","volume":"111","author":"Li","year":"2003","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12728_bb0045","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1161\/CIRCULATIONAHA.109.900589","article-title":"Association of cyclooxygenase\u20101\u2010dependent and \u2010independent platelet function assays with adverse clinical outcomes in aspirin\u2010treated patients presenting for cardiac catheterization","volume":"120","author":"Frelinger","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/jth.12728_bb0050","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2008.10.047","article-title":"Platelet cyclooxygenase inhibition by low\u2010dose aspirin is not reflected consistently by platelet function assays: implications for aspirin \u201cresistance\u201d","volume":"53","author":"Santilli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12728_bb0055","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1538-7836.2007.02387.x","article-title":"Reticulated platelets and uninhibited COX\u20101 and COX\u20102 decrease the antiplatelet effects of aspirin","volume":"5","author":"Guthikonda","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0060","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1161\/CIRCULATIONAHA.106.675587","article-title":"Evaluation of dose\u2010related effects of aspirin on platelet function: results from the Aspirin\u2010Induced Platelet Effect (ASPECT) study","volume":"115","author":"Gurbel","year":"2007","journal-title":"Circulation"},{"key":"10.1111\/jth.12728_bb0065","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1160\/TH12-07-0532","article-title":"High on treatment platelet reactivity against aspirin by non\u2010steroidal anti\u2010inflammatory drugs\u2013pharmacological mechanisms and clinical relevance","volume":"109","author":"Hohlfeld","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0070","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ahj.2009.11.033","article-title":"Hypothesis formulation from subgroup analyses: nonadherence of nonsteroidal anti\u2010inflammatory dtug use explains the lack of clinical benefit of aspirin on first myocardial infarction attributed to aspirin resistance","volume":"159","author":"Hennekens","year":"2010","journal-title":"Am Heart J"},{"key":"10.1111\/jth.12728_bb0075","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta\u2010analysis of individual participant data from randomized trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/jth.12728_bb0080","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes","volume":"363","author":"Mehta","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12728_bb0085","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","article-title":"Aspirin in patients undergoing noncardiac surgery","volume":"370","author":"Devereaux","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12728_bb0090","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood-2006-01-010645","article-title":"Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions","volume":"109","author":"Undas","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.12728_bb0095","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/bmj.308.6923.235","article-title":"Collaborative overview of randomised trials of antiplatelet therapy\u2010III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients","volume":"308","year":"1994","journal-title":"BMJ"},{"issue":"6 Suppl.","key":"10.1111\/jth.12728_bb0100","doi-asserted-by":"crossref","first-page":"381S","DOI":"10.1378\/chest.08-0656","article-title":"Prevention of venous thromboembolism: American College of Chest Physicians Evidence\u2010Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Geerts","year":"2008","journal-title":"Chest"},{"issue":"2 Suppl.","key":"10.1111\/jth.12728_bb0105","doi-asserted-by":"crossref","first-page":"e278S","DOI":"10.1378\/chest.11-2404","article-title":"Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence\u2010based clinical practice guidelines","volume":"141","author":"Falck\u2010Ytter","year":"2012","journal-title":"Chest"},{"issue":"2 Suppl.","key":"10.1111\/jth.12728_bb0110","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence\u2010based clinical practice guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"issue":"2 Suppl.","key":"10.1111\/jth.12728_bb0115","doi-asserted-by":"crossref","first-page":"e195S","DOI":"10.1378\/chest.11-2296","article-title":"Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence\u2010based clinic al practice guidelines","volume":"141","author":"Kahn","year":"2012","journal-title":"Chest"},{"key":"10.1111\/jth.12728_bb0120","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","article-title":"Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/jth.12728_bb0125","doi-asserted-by":"crossref","first-page":"800","DOI":"10.7326\/0003-4819-158-11-201306040-00004","article-title":"Aspirin versus low\u2010molecular\u2010weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial","volume":"158","author":"Anderson","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1111\/jth.12728_bb0130","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"Becattini","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12728_bb0135","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low\u2010dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1111\/jth.12728_bb0140","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/0268355512475040","article-title":"Aspirin and recurrent venous thromboembolism","volume":"28","author":"Prandoni","year":"2013","journal-title":"Phlebology"},{"key":"10.1111\/jth.12728_bb0145","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1538-7836.2009.03279.x","article-title":"Arterial cardiovascular events, statins, low dose aspirin and subsequent risk of venous thromboembolism: a population\u2010based case\u2013control study","volume":"7","author":"S\u00f8rensen","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0150","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/j.1538-7836.2012.04865.x","article-title":"Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis. Retrospective cohort study","volume":"10","author":"Milan","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0155","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/ATVBAHA.111.242859","article-title":"Neutrophil extracellular trap (NET) impact on deep vein thrombosis","volume":"32","author":"Fuchs","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12728_bb0160","doi-asserted-by":"crossref","first-page":"557","DOI":"10.20452\/pamw.1464","article-title":"Coagulation and the vessel wall in thrombosis and atherosclerosis","volume":"122","author":"Kleinegris","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"10.1111\/jth.12728_bb0165","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ehj.2003.08.021","article-title":"The adhesion molecule P\u2010selectin and cardiovascular disease","volume":"24","author":"Blann","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.12728_bb0170","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jvs.2005.04.045","article-title":"Decreased venous thrombosis with an oral inhibitor of P selectin","volume":"42","author":"Myers","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.1111\/jth.12728_bb0175","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1160\/TH07-10-0608","article-title":"Prophylactic P\u2010selectin inhibition with PSI\u2010421 promotes resolution of venous thrombosis without anticoagulation","volume":"99","author":"Meier","year":"2008","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0180","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1160\/TH05-06-0426","article-title":"D\u2010dimer, P\u2010selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study","volume":"94","author":"Rectenwald","year":"2005","journal-title":"Thromb Haemos"},{"issue":"6 Suppl.","key":"10.1111\/jth.12728_bb0185","doi-asserted-by":"crossref","first-page":"48S","DOI":"10.1016\/j.jvs.2011.05.097","article-title":"Soluble P\u2010selectin, D\u2010dimer, and high\u2010sensitivity C\u2010reactive protein after acute deep vein thrombosis of the lower limb","volume":"54","author":"Gremmel","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1111\/jth.12728_bb0190","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.jacc.2004.12.075","article-title":"Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism","volume":"45","author":"Chirinos","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12728_bb0195","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1538-7836.2009.03680.x","article-title":"High platelet count associated with venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)","volume":"8","author":"Simanek","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0200","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1538-7836.2009.03498.x","article-title":"Mean platelet volume is a risk factor for venous thromboembolism: the Troms\u00f8 Study, Troms\u00f8, Norway","volume":"8","author":"Braekkan","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0205","first-page":"1391","article-title":"Critical role of von Willebrand factor and platelet interaction in venous thromboembolism","volume":"24","author":"Takahashi","year":"2009","journal-title":"Histol Histopathol"},{"key":"10.1111\/jth.12728_bb0210","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1084\/jem.20112322","article-title":"Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo","volume":"209","author":"von Br\u00fchl","year":"2012","journal-title":"J Exp Med"},{"key":"10.1111\/jth.12728_bb0215","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1182\/blood-2010-05-287623","article-title":"von Willebrand factor\u2010mediated platelet adhesion is critical for deep vein thrombosis in mouse models","volume":"117","author":"Brill","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.12728_bb0220","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1182\/blood-2009-11-254029","article-title":"Polyphosphate modifies the fibrin network and down\u2010regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin","volume":"115","author":"Mutch","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.12728_bb0225","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1182\/blood-2010-01-266791","article-title":"Polyphosphate exerts differential effects on blood clotting, depending on polymer size","volume":"116","author":"Smith","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.12728_bb0230","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1161\/ATVBAHA.108.177402","article-title":"Tissue factor in coagulation: which? where? when?","volume":"29","author":"Butenas","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12728_bb0235","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-0038-1651063","article-title":"Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation ex vivo in man: effect of low\u2010dose aspirin","volume":"57","author":"Kyrle","year":"1987","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0240","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0735-1097(99)00023-6","article-title":"Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia","volume":"33","author":"Szczeklik","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/jth.12728_bb0245","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-0038-1647146","article-title":"Coagulation, fibrinolytic and platelet function in patients in long\u2010term therapy with 300\u00a0mg or 1200\u00a0mg daily compared with placebo","volume":"64","author":"Hampton","year":"1990","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0250","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1055\/s-0038-1648815","article-title":"Measurement of thrombin generation in whole blood \u2013 the effect of heparin and aspirin","volume":"72","author":"Kessels","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0255","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0049-3848(98)00126-1","article-title":"Influence of low\u2010 and high\u2010dose aspirin treatment on thrombin generation in whole blood","volume":"92","author":"Wallen","year":"1998","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12728_bb0260","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1182\/blood.V97.8.2314","article-title":"Antiplatelet agents in tissue factor\u2010induced blood coagulation","volume":"97","author":"Butenas","year":"2000","journal-title":"Blood"},{"key":"10.1111\/jth.12728_bb0265","first-page":"231","article-title":"A low dose of aspirin (75\u00a0mg\/day) lowers thrombin generation to a similar extent as a high dose of aspirin (300\u00a0mg\/day)","volume":"11","author":"Undas","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12728_bb0270","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood.V98.8.2423","article-title":"Blood coagulation at the site of microvascular injury: effects of low\u2010dose aspirin","volume":"98","author":"Undas","year":"2001","journal-title":"Blood"},{"key":"10.1111\/jth.12728_bb0275","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1182\/blood.V80.8.2006.2006","article-title":"Antiplatelet drugs and generation of thrombin in clotting blood","volume":"80","author":"Szczeklik","year":"1992","journal-title":"Blood"},{"key":"10.1111\/jth.12728_bb0280","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0037-1615701","article-title":"Treatment with simvastatin and low\u2010dose aspirin depresses thrombin generation in patients with coronary heart disease and borderline\u2010high cholesterol levels","volume":"85","author":"Musial","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0285","first-page":"392","article-title":"Anticoagulant effects of statins and their clinical implications","volume":"111","author":"Undas","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0290","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1055\/s-0038-1650694","article-title":"Acetylsalicylic acid and sodium salicylate inhibit LPS\u2010induced NF\u2010kB\/c\u2010Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alpha (TNF\u2010alpha) in human monocytes","volume":"76","author":"Osnes","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0295","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.CIR.102.6.602","article-title":"Smoking increases tissue factor expression in atherosclerotic plaques: implications for thrombogenicity","volume":"102","author":"Matetzky","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/jth.12728_bb0300","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.thromres.2010.11.018","article-title":"Immunomodulatory drugs increase endothelial tissue factor expression in vitro","volume":"127","author":"Valsami","year":"2011","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12728_bb0305","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijcard.2010.12.030","article-title":"Increased platelet residual activity in patients treated with acetosalicylic acid is associated with increased tissue factor and decreased tissue factor pathway inhibitor plasma levels","volume":"146","author":"Vojacek","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1111\/jth.12728_bb0310","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2362.2010.02299.x","article-title":"Low dose acetylsalicylic acid and shedding of microparticles in vivo in humans","volume":"40","author":"Lubsczyk","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/jth.12728_bb0315","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1055\/s-0038-1647530","article-title":"Effect of oral aspirin on plasma levels of vitamin K\u2010dependent clotting factors studied in healthy volunteers","volume":"59","author":"Cattaneo","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0320","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/abio.1999.4148","article-title":"Acetylated prothrombin as a substrate in the measurement of the procoagulant activity of platelets: elimination of the feedback activation of platelets by thrombin","volume":"272","author":"Jesty","year":"1999","journal-title":"Anal Biochem"},{"key":"10.1111\/jth.12728_bb0325","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-0038-1646320","article-title":"Decreased platelet membrane fluidity due glycation or acetylation of membrane proteins","volume":"68","author":"Winocour","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0330","first-page":"367","article-title":"Aspirin delays thrombin generation in vitro through interaction with platelet phospholipids","volume":"85","author":"Musia\u0142","year":"1997","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12728_bb0335","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/01.ATV.16.8.948","article-title":"Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia","volume":"16","author":"Szczeklik","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12728_bb0340","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/hc4701.099787","article-title":"PlA2 polymorphism of \u03b23 integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury","volume":"104","author":"Undas","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/jth.12728_bb0345","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1046\/j.1365-2141.2000.02267.x","article-title":"Relationship between bleeding time, aspirin, and the PlA1\/A2 of platelet glycoprotein IIIa","volume":"110","author":"Szczeklik","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12728_bb0350","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1126\/science.1172484","article-title":"Multiscale mechanics of fibrin polymer: gel stretching with protein unfolding and loss of water","volume":"325","author":"Brown","year":"2009","journal-title":"Science"},{"key":"10.1111\/jth.12728_bb0355","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1161\/ATVBAHA.111.230631","article-title":"Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases","volume":"31","author":"Undas","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12728_bb0360","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1161\/ATVBAHA.110.213389","article-title":"Molecular mechanisms affecting fibrin structure and stability","volume":"31","author":"Lord","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12728_bb0365","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1053\/euhj.1998.1088","article-title":"Better increase in fibrin gel porosity by low dose than intermediate dose acetylsalicylic acid","volume":"19","author":"Williams","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.12728_bb0370","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.thromres.2005.02.007","article-title":"Marked increase of fibrin gel permeability with very low dose ASA treatment","volume":"116","author":"Antovic","year":"2005","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12728_bb0375","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/oxfordjournals.eurheartj.a015070","article-title":"Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient?","volume":"17","author":"Fatah","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1111\/jth.12728_bb0380","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/00001721-199512000-00004","article-title":"The effect of acetyl salicylic acid on fibrin gel lysis by tissue plasminogen activator","volume":"6","author":"Williams","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.12728_bb0385","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/FJC.0b013e3181953e0f","article-title":"Effects of acetylsalicylic acid on increase of fibrin network porosity and the consequent upregulation of fibrinolysis","volume":"53","author":"He","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/jth.12728_bb0390","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/ATVBAHA.109.183707","article-title":"Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system","volume":"29","author":"Ajjan","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12728_bb0395","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0022-3565(25)21331-3","article-title":"Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels","volume":"250","author":"Bjornsson","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/jth.12728_bb0400","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2012.03.154","article-title":"Acetylation and glycation of fibrinogen in vitro occur at specific lysine residues in a concentration dependent manner: a mass spectrometric and isotope labeling study","volume":"421","author":"Svensson","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/jth.12728_bb0405","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1008859729045","article-title":"Prothrombotic consequences of the oxidation of fibrinogen and their inhibition by aspirin","volume":"5","author":"Upchurch","year":"1998","journal-title":"J Thromb Thrombolysis"},{"key":"10.1111\/jth.12728_bb0410","first-page":"161","article-title":"Alterations of fibrinogen structure in human disease","volume":"6","author":"Hoffman","year":"2008","journal-title":"Cardiovasc Hematol Agents Medicinal Chem"},{"key":"10.1111\/jth.12728_bb0415","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1021\/bi052076j","article-title":"Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia","volume":"45","author":"Sauls","year":"2006","journal-title":"Biochemistry"},{"key":"10.1111\/jth.12728_bb0420","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/01.CIR.0000047062.03282.A3","article-title":"Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism","volume":"107","author":"Undas","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/jth.12728_bb0425","doi-asserted-by":"crossref","first-page":"e71150","DOI":"10.1371\/journal.pone.0071150","article-title":"Fibrin clot structure and platelet aggregation in patients with aspirin treatment failure","volume":"8","author":"Neergaard\u2010Petersen","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.12728_bb0430","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1182\/blood-2009-05-222380","article-title":"Altered fibrin clot structure\/function in patients with idiopathic venous thromboembolism and in their relatives","volume":"114","author":"Undas","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12728_bb0435","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.atherosclerosis.2007.05.028","article-title":"Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress","volume":"196","author":"Undas","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1111\/jth.12728_bb0440","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/01.ATV.0000241589.52950.4c","article-title":"Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis","volume":"26","author":"Collet","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.12728_bb0445","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/STROKEAHA.108.532812","article-title":"Altered fibrin clot structure\/function as a novel risk factor for cryptogenic ischemic stroke","volume":"40","author":"Undas","year":"2009","journal-title":"Stroke"},{"key":"10.1111\/jth.12728_bb0450","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.thromres.2010.09.011","article-title":"Decreased fibrin clot network permeability and impaired fibrinolysis in the acute and convalescent phase of ischemic stroke","volume":"127","author":"Rooth","year":"2011","journal-title":"Thromb Res"},{"key":"10.1111\/jth.12728_bb0455","doi-asserted-by":"crossref","first-page":"608","DOI":"10.20452\/pamw.1535","article-title":"Altered fibrin clot properties in patients with premature peripheral artery disease","volume":"122","author":"Okraska\u2010Bylica","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"10.1111\/jth.12728_bb0460","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/j.1538-7836.2007.02637.x","article-title":"Altered fibrin clot structure in patients with advanced coronary artery disease: a role of C\u2010reactive protein, lipoprotein(a), and homocysteine","volume":"5","author":"Undas","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0465","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1538-7836.2006.01882.x","article-title":"Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease","volume":"4","author":"Undas","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0470","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1538-7836.2011.04544.x","article-title":"Neutrophil extracellular traps promote deep vein thrombosis in mice","volume":"10","author":"Brill","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0475","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/jth.12571","article-title":"Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development","volume":"12","author":"Savchenko","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0480","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/jpet.112.202879","article-title":"Regulation of neutrophil extracellular trap formation by anti\u2010inflammatory drugs","volume":"345","author":"Lapponi","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/jth.12728_bb0485","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1172\/JCI61303","article-title":"Platelets induce neutrophil extracellular traps in transfusion\u2010related acute lung injury","volume":"122","author":"Caudrillier","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.12728_bb0490","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-2007-1003553","article-title":"Acetylation of antithrombin III by aspirin","volume":"12","author":"Villanueva","year":"1986","journal-title":"Semin Thromb Haemost"},{"key":"10.1111\/jth.12728_bb0495","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/219068a0","article-title":"In vitro acetylation of plasma proteins, enzymes and DNA by aspirin","volume":"219","author":"Pinckard","year":"1968","journal-title":"Nature"},{"key":"10.1111\/jth.12728_bb0500","first-page":"239","article-title":"Dose\u2010dependent influence of acetylsalicylic acid on platelet functions and plasmatic coagulation factors","volume":"5","author":"Loew","year":"1976","journal-title":"Haemostasis"},{"key":"10.1111\/jth.12728_bb0505","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1160\/TH05-05-0359","article-title":"Anti\u2010thrombotic action of clopidogrel and P1(A1\/A2) polymorphism of beta3 integrin in patients with coronary artery disease not being treated with aspirin","volume":"94","author":"Dropinski","year":"2005","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12728","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12728","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362204106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362204106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12728\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:09:34Z","timestamp":1761534574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362204106X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":100,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S153878362204106X"],"URL":"https:\/\/doi.org\/10.1111\/jth.12728","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12728","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}